PEN Penumbra, Inc. Common Stock
NYSE · Health Care · Voir sur SEC EDGAR ↗ clôture Oct 2, 2026 10-K/10-Q Jul 30, 2026
$317,55
· % de la fourchette 52 sem.
· au-dessus du plus bas
· vers le haut
$221,26Bas 52 semaines
$362,41Haut 52 semaines
Capitalisation Boursière
$12.46B
P/E (TTM)
78.0
BPA (TTM)
$4.07
Revenu (TTM)
$1.50B
vos badges
Fourchette 52 semaines
$221–$362
Note des analystes
HOLD
Objectif de cours
$362
P/E
78.0
ROE
11.4%
Marge nette
10.7%
Votre barre de badges est vide — épinglez une métrique n'importe où sur cette page.
PEN Aperçu de l'action Prix, capitalisation boursière, P/E, EPS, ROE, dette/capitaux propres, fourchette sur 52 semaines
Prix
$317.55
Capitalisation Boursière
$12.46B
P/E (TTM)
78.0
BPA (TTM)
$4.07
Revenu (TTM)
$1.50B
ROE (TTM)
11.4%
Fourchette 52 semaines
$221–$362
PEN Graphique du cours de l'action OHLCV quotidien avec indicateurs techniques — panoramique, zoom et personnalisez votre vue
fourchette
barres
La granularité des barres s'adapte à la période sélectionnée — survolez le graphique pour voir l'ouverture/le maximum/le minimum/la clôture d'une barre.
À propos de Penumbra, Inc. Common Stock Présentation de l'entreprise depuis Wikipedia
Penumbra, Inc. is an American medical device company headquartered in Alameda, California. The company was founded by Arani Bose and Adam Elsesser in 2004. It manufactures devices for interventional therapies to treat vascular conditions such as stroke and aneurysm.
In January 2026, Boston Scientific announced it would acquire Penumbra in a $15 billion cash and stock deal. The deal was expected to close by year-end.
History
Penumbra was founded in 2004 and manufactures several medical devices but specializes in the neuro/vascular market and creates devices that help treat aneurysms and ischemic stroke.
In 2014, Penumbra launched its Apollo system, a device that “enables minimally invasive removal of deeply seated tissue and fluids in the brain,” allowing for otherwise inoperable blood clots to be removed.
In 2015 the company issued an initial public offering on the New York Stock Exchange. In 2018 the company acquired 40% of the outstanding shares of virtual reality joint venture MVI Health. In 2017 the company acquired the Italian distributor Crossmed.
Criticism
Criticism of Penumbra has followed various aspects of its products and business practices. In 2016 a lawsuit claimed the Penumbra Coil 400 caused brain damage after surgery. The company's specialized catheter has been linked to the deaths of stroke patients, and it was a target of stock short sellers in 2020. According to the Foundation for Financial Journalism, this is a significant dilemma.
A request has been sent to The SEC and U.S. Food and Drug Administration to launch an investigation. A scientist who has published research articles showing the reliability of Penumbra's medical products is (allegedly) an internet fabrication.
Recalls
In 2011 the company recalled its Penumbra Coil 400. In 2017 the company recalled a 3D revascularization device. In 2020 the company recalled one of its catheter used during heart surgery due to increased risk of mortality and serious injury.
Source : Wikipedia (Anglais), CC BY-SA 4.0 · Voir sur Wikipedia ↗
secteurHealth Care
industrieHealth Care
employés4 700
paysUS
Performance sur 10 ans Tendances du chiffre d'affaires, du bénéfice net, des marges et du BPA
Revenu$1.40B2018-12-31 → 2025-12-31
BPA$4.522018-12-31 → 2025-12-31
Flux de trésorerie libre$175M2018-12-31 → 2025-12-31
Marge nette10.7%2018-12-31 → 2025-12-31
Valorisation et Ratios
Valorisation Ratios P/E, P/S, P/B, EV/EBITDA — l'action est-elle chère ou bon marché ?
| Métrique | Tendance sur 5 ans | PEN | moyenne 5 ans | Médiane des pairs | Verdict |
|---|---|---|---|---|---|
| P/E (TTM) | 78.0moyenne 5 ans ≈-312.0 | ≈-312.0 | 23.8 | Surévalué | |
| P/S | 8.9moyenne 5 ans ≈10.0 | ≈10.0 | 3.9 | Surévalué | |
| P/B | 8.7moyenne 5 ans ≈8.9 | ≈8.9 | 4.6 | Surévalué | |
| Price / FCF (Cours / FCF) | 71.2moyenne 5 ans ≈-157.5 | ≈-157.5 | · | · | |
| Price / Cash Flow (Cours / Flux de trésorerie) | 52.2moyenne 5 ans ≈237.9 | ≈237.9 | 17.3 | Surévalué | |
| Price / Tangible Book (Cours / Actif net tangible) | 9.9moyenne 5 ans ≈11.2 | ≈11.2 | · | · |
La médiane des pairs est calculée sur une base standardisée par métrique et peut ne pas toujours correspondre à la base TTM/MRQ indiquée pour cette action.
Rentabilité Marges brutes, d'exploitation et nettes ; ROE, ROA, ROIC
| Métrique | Tendance sur 5 ans | PEN | moyenne 5 ans | Médiane des pairs | Verdict |
|---|---|---|---|---|---|
| Marge Brute (TTM) | 67.8%moyenne 5 ans ≈64.3% | ≈64.3% | 62.3% | Premier rang | |
| Marge d'exploitation (TTM) | 12.4%moyenne 5 ans ≈4.2% | ≈4.2% | 14.5% | Faible | |
| Marge EBITDA (TTM) | 13.6%moyenne 5 ans ≈6.4% | ≈6.4% | 14.5% | Faible | |
| Marge avant impôts (TTM) | 13.5%moyenne 5 ans ≈4.6% | ≈4.6% | 12.6% | Faible | |
| Marge nette (TTM) | 10.7%moyenne 5 ans ≈4.6% | ≈4.6% | 9.8% | Faible | |
| ROA (TTM) | 8.8%moyenne 5 ans ≈3.6% | ≈3.6% | 7.8% | Premier rang | |
| ROE (TTM) | 11.4%moyenne 5 ans ≈4.5% | ≈4.5% | 13.1% | En ligne | |
| ROIC | 11.5%moyenne 5 ans ≈3.8% | ≈3.8% | 9.9% | Premier rang |
Santé financière Dette, liquidité, solvabilité — solidité du bilan
| Métrique | Tendance sur 5 ans | PEN | moyenne 5 ans | Médiane des pairs | Verdict |
|---|---|---|---|---|---|
| Ratio de liquidité (MRQ) | 5.7moyenne 5 ans ≈5.9 | ≈5.9 | 2.2 | Liquidité solide | |
| Quick Ratio (Ratio de liquidité réduite) | 2.1moyenne 5 ans ≈2.2 | ≈2.2 | 1.1 | Liquidité solide |
Croissance Croissance du chiffre d'affaires, du BPA et du bénéfice net : Année/Année, TCAC 3 ans, TCAC 5 ans
| Métrique | Tendance sur 5 ans | PEN | moyenne 5 ans | Médiane des pairs | Verdict |
|---|---|---|---|---|---|
| Revenue YoY (Chiffre d'affaires YoY) | 17.5%moyenne 5 ans ≈20.4% | ≈20.4% | · | · | |
| Revenue CAGR 3Y (CAGR du chiffre d'affaires 3 ans) | 18.3%moyenne 5 ans ≈19.6% | ≈19.6% | · | · | |
| Revenue CAGR 5Y (CAGR du chiffre d'affaires 5 ans) | 20.2% | · | · | · | |
| EPS YoY (BPA Année/Année) | 1155.6% | · | · | · | |
| Net Income YoY (Bénéfice net YoY) | 1168.1% | · | · | · | |
| EPS CAGR 3Y (TCAC BPA 3 ans) | 37.0% | · | · | · | |
| Net Income CAGR 3Y (TCAC Bénéfice net 3 ans) | 38.4% | · | · | · |
Efficacité du capital Rotation des actifs, rotation des stocks, rotation des créances
| Métrique | Tendance sur 5 ans | PEN | moyenne 5 ans | Médiane des pairs | Verdict |
|---|---|---|---|---|---|
| Asset Turnover (Rotation des actifs) | 0.8moyenne 5 ans ≈0.7 | ≈0.7 | 0.6 | Premier rang | |
| Inventory Turnover (Rotation des stocks) | 1.1moyenne 5 ans ≈1.1 | ≈1.1 | 1.8 | Faible | |
| Receivables Turnover (Rotation des créances) | 7.8moyenne 5 ans ≈6.0 | ≈6.0 | 5.8 | Premier rang | |
| Revenue / Employee (Chiffre d'affaires annuel ÷ employés (effectif déclaré, yfinance). Dérivé — pas un concept SEC-XBRL stocké.) | ≈$298.7K | · | · | · |
valeur · ≈ moyenne 5 ans · médiane du secteur · verdict par rapport à la médiane
Historique des bénéfices BPA réel vs estimation, surprise %, taux de succès, prochaine date de publication des résultats
Surprise Moyenne
-2.4%
Prochain rapport
Nov 03, 2026
| Période | Rapport | EPS Actual | BPA est. | Surprise |
|---|---|---|---|---|
| 30 juin 2026 | Jul 27, 2026 | $0.88 | $1.20 | -26.6% |
| 31 mars 2026 | $0.82 | $1.09 | -24.5% | |
| 31 décembre 2025 | $1.18 | $1.12 | 5.0% | |
| 30 septembre 2025 | $0.97 | $0.93 | 4.2% | |
| 30 juin 2025 | $0.86 | $0.83 | 3.6% | |
| 31 mars 2025 | $0.83 | $0.67 | 23.9% |
Fondamentaux complets Tous les indicateurs par an — compte de résultat, bilan, flux de trésorerie
Compte de résultat
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.40B | $1.19B | $1.06B | $847M | $748M | $560M | $547M | · | $334M | $263M | |
| Cost of Revenue | $461M | $440M | $376M | $312M | $272M | $222M | $175M | · | $117M | $92M | |
| Gross Profit | $942M | $755M | $683M | $535M | $475M | $338M | $372M | · | $217M | $171M | |
| R&D Expense | · | · | · | · | · | · | · | · | $32M | $24M | |
| SG&A Expense | $663M | $574M | $506M | $450M | $378M | $287M | $273M | · | $184M | $148M | |
| Operating Expenses | $753M | $746M | $609M | $529M | $483M | $377M | $324M | · | $216M | $172M | |
| Operating Income | $189M | $9M | $74M | $6M | $-8M | $-39M | $48M | · | $1M | $-1M | |
| Interest Expense | · | · | $2M | $2M | $2M | · | · | · | · | · | |
| Interest Income | $16M | $14M | $7M | $2M | $3M | · | · | · | · | · | |
| Other Non-op | $893.0K | $-682.0K | $1M | $-2M | $-4M | $-343.0K | $-227.0K | · | $-1M | $-2M | |
| Pretax Income | $205M | $21M | $80M | $4M | $-11M | $-38M | $50M | · | $2M | $-869.0K | |
| Income Tax | $27M | $7M | $-11M | $6M | $-13M | $-19M | $3M | · | $-4M | $-16M | |
| Net Income | $178M | $14M | $91M | $-2M | $5M | $-16M | $48M | · | $5M | $15M | |
| EPS (Basic) | $4.57 | $0.36 | $2.37 | $-0.05 | $0.14 | $-0.44 | $1.39 | · | $0.14 | $0.49 | |
| EPS (Diluted) | $4.52 | $0.36 | $2.32 | $-0.05 | $0.14 | $-0.44 | $1.34 | · | $0.13 | $0.44 | |
| Shares (Basic) | 38,918,493 | 38,633,744 | 38,401,171 | 37,841,874 | 36,764,290 | 35,766,892 | 34,750,706 | · | 32,978,065 | 30,464,583 | |
| Shares (Diluted) | 39,291,828 | 39,268,037 | 39,216,564 | 37,841,874 | 37,881,180 | 35,766,892 | 36,265,999 | · | 35,319,103 | 33,478,078 | |
| EBITDA | $207M | $33M | $101M | $30M | $9M | $-26M | $56M | · | $5M | $950.0K |
Bilan
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $187M | $324M | $167M | $70M | $59M | $70M | $73M | · | $51M | $13M | |
| Short-term Investments | · | · | · | · | · | $195M | $117M | · | $164M | $116M | |
| Receivables | $190M | $168M | $202M | $203M | $134M | $115M | $106M | · | $58M | $43M | |
| Inventory | $432M | $407M | $388M | $334M | $264M | $220M | $153M | · | $95M | $73M | |
| Prepaid Expense | $50M | $37M | $36M | $30M | $29M | $19M | $15M | $12M | $15M | $19M | |
| Other Current Assets | · | · | · | · | · | · | · | · | $7M | $9M | |
| Current Assets | $1.22B | $951M | $915M | $756M | $681M | $618M | $463M | $410M | $382M | $264M | |
| PP&E (Net) | $117M | $63M | $73M | $65M | $59M | $48M | $52M | · | $31M | $21M | |
| PP&E (Gross) | $194M | $137M | $132M | $113M | $97M | $78M | $73M | · | $41M | $28M | |
| Accum. Depreciation | $77M | $74M | $60M | $48M | $38M | $30M | $21M | · | $11M | $7M | |
| Goodwill | $167M | $166M | $166M | $166M | $166M | $8M | $8M | · | $8M | $0 | |
| Intangibles | $6M | $7M | $71M | $81M | $91M | $11M | $25M | · | $24M | $0 | |
| Other Non-current Assets | $41M | $41M | $26M | $13M | $13M | $9M | $3M | · | $1M | $487.0K | |
| Total Assets | $1.83B | $1.53B | $1.56B | $1.37B | $1.24B | $823M | $666M | $558M | $477M | $308M | |
| Accounts Payable | $35M | $31M | $27M | $27M | $13M | $14M | $15M | · | $7M | $4M | |
| Accrued Liabilities | $132M | $112M | $111M | $106M | $100M | $86M | $68M | $58M | $45M | $32M | |
| Current Liabilities | $183M | $158M | $151M | $145M | $123M | $106M | $91M | $70M | $52M | $36M | |
| Capital Leases | $183M | $187M | $197M | $199M | $137M | $44M | $47M | $47M | · | · | |
| Deferred Tax | · | · | · | · | · | · | $4M | · | $3M | $824.0K | |
| Other Non-current Liabilities | $12M | $15M | $5M | $3M | $4M | $8M | $15M | · | $18M | $824.0K | |
| Total Liabilities | $399M | $382M | $377M | $372M | $290M | $185M | $180M | $135M | $76M | $42M | |
| Common Stock | $39.0K | $38.0K | $39.0K | $38.0K | $37.0K | $36.0K | $35.0K | · | $33.0K | $31.0K | |
| Paid-in Capital | $1.19B | $1.10B | $1.05B | $963M | $911M | $598M | $431M | · | $397M | $274M | |
| Retained Earnings | $238M | $60M | $135M | $44M | $46M | $41M | $58M | · | $2M | $-3M | |
| AOCI | $4M | $-6M | $-3M | $-8M | $-3M | $3M | $-2M | · | $2M | $-5M | |
| Stockholders' Equity | $1.43B | $1.15B | $1.18B | $999M | $954M | $638M | $486M | · | $400M | $267M | |
| Liabilities + Equity | $1.83B | $1.53B | $1.56B | $1.37B | $1.24B | $823M | $666M | $558M | $477M | $308M | |
| Shares Outstanding | 39,229,670 | 38,490,836 | 38,681,549 | 38,107,977 | 37,578,483 | 36,414,732 | 35,001,581 | · | 33,685,146 | 31,108,828 |
Flux de trésorerie
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $17M | $24M | $27M | $24M | $16M | $13M | $8M | · | $4M | $2M | |
| Stock-based Comp | $59M | $46M | $51M | $37M | $66M | $26M | $21M | · | $18M | $15M | |
| Deferred Tax | $21M | $-16M | $-25M | $1M | $-15M | $-20M | $1M | · | $-5M | $-13M | |
| Amort. of Intangibles | $712.0K | $5M | $10M | $9M | $3M | $1M | $1M | · | $418.0K | $0 | |
| Restructuring | · | $5M | · | · | · | · | · | · | · | · | |
| Other Non-cash | $-37M | $101M | $-46M | $-116M | $-63M | $-36M | $-53M | · | $-9M | $-32M | |
| Operating Cash Flow | $239M | $168M | $97M | $-56M | $10M | $-33M | $27M | · | $13M | $-13M | |
| CapEx | $64M | $21M | $15M | $19M | $21M | $25M | $22M | · | $13M | $14M | |
| Investing Cash Flow | $-405M | $78M | $-16M | $55M | $-22M | $-104M | $-13M | · | $-78M | $687.0K | |
| Stock Issued | · | · | · | $0 | $0 | $135M | $0 | · | $106M | $0 | |
| Stock Repurchased | $0 | $100M | $0 | $0 | · | · | · | · | · | · | |
| Net Stock Activity | $0 | $-100M | · | $0 | $0 | $135M | $0 | · | $106M | · | |
| Financing Cash Flow | $27M | $-87M | $16M | $12M | $836.0K | $135M | $-9M | · | $104M | $7M | |
| Net Change in Cash | $-138M | $157M | $98M | $10M | $-10M | $-3M | $5M | · | $37M | $-6M | |
| Taxes Paid | $15M | · | · | · | · | · | · | · | · | · | |
| Free Cash Flow | $175M | $147M | $82M | $-75M | $-12M | $-58M | $5M | · | $159.0K | $-26M | |
| Levered FCF | · | · | $80M | · | · | · | · | · | · | · |
Rentabilité
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 67.1% | 63.2% | 64.5% | 63.2% | 63.6% | 60.3% | 68.0% | · | 65.1% | 64.9% | |
| Operating Margin | 13.5% | 0.78% | 7.0% | 0.72% | -1.0% | -7.0% | 8.7% | · | 0.35% | -0.51% | |
| Net Margin | 12.7% | 1.2% | 8.6% | -0.24% | 0.71% | -2.8% | 8.8% | · | 1.4% | 5.6% | |
| Pretax Margin | 14.6% | 1.8% | 7.5% | 0.46% | -1.4% | -6.8% | 9.2% | · | 0.74% | -0.33% | |
| EBITDA Margin | 14.7% | 2.8% | 9.5% | 3.6% | 1.2% | -4.7% | 10.2% | · | 1.5% | 0.36% | |
| ROA | 10.6% | 0.91% | 6.2% | -0.15% | 0.49% | -2.1% | 7.9% | · | 1.2% | 4.8% | |
| ROE | 13.1% | 1.2% | 8.0% | -0.20% | 0.64% | -2.8% | 10.7% | · | 1.4% | 5.6% | |
| ROIC | 11.5% | 0.54% | 7.1% | -0.31% | 0.20% | -3.1% | 9.2% | · | 0.72% | 8.6% |
Liquidité et Solvabilité
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 6.6 | 6.0 | 6.1 | 5.2 | 5.5 | 5.8 | 5.1 | · | 7.4 | 7.4 | |
| Quick Ratio | 2.1 | 3.1 | 2.4 | 1.9 | 1.6 | 3.6 | 3.2 | · | 5.3 | 4.8 | |
| Interest Coverage | · | · | 42.3 | · | · | · | · | · | · | · |
Efficacité
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.8 | 0.8 | 0.7 | 0.6 | 0.7 | 0.8 | 0.9 | · | 0.9 | 0.9 | |
| Inventory Turnover | 1.1 | 1.1 | 1.0 | 1.0 | 1.1 | 1.2 | 1.3 | · | 1.4 | 1.4 | |
| Receivables Turnover | 7.8 | 6.5 | 5.2 | 5.0 | 5.5 | 5.1 | 5.8 | · | 6.6 | 7.2 |
Par action
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $36.39 | $29.90 | $30.48 | $26.21 | $25.38 | $17.62 | $13.88 | · | $11.89 | $8.57 | |
| Revenue / Share | $35.72 | $30.42 | $26.99 | $22.39 | $19.74 | $15.67 | $15.09 | · | $9.45 | $7.87 | |
| Cash Flow / Share | $6.07 | $4.29 | $2.48 | $-1.47 | $0.25 | $-0.93 | $0.73 | · | $0.36 | $-0.38 | |
| Cash / Share | $4.76 | $8.43 | $4.33 | $1.83 | $1.58 | $1.91 | $2.08 | · | $1.50 | $0.43 | |
| EPS (TTM) | $4.52 | $0.36 | $2.32 | $-0.05 | $0.14 | $-0.44 | $1.34 | · | $0.13 | $0.44 |
Taux de croissance
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 17.5% | 12.9% | 24.9% | 13.3% | 33.4% | · | · | · | · | · | |
| Revenue CAGR 3Y | 18.3% | 16.9% | 23.6% | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 20.2% | · | · | · | · | · | · | · | · | · | |
| EPS YoY | 1155.6% | -84.5% | · | · | · | · | · | · | · | · | |
| EPS CAGR 3Y | · | 37.0% | · | · | · | · | · | · | · | · | |
| Net Income YoY | 1168.1% | -84.6% | · | · | · | · | · | · | · | · | |
| Net Income CAGR 3Y | · | 38.4% | · | · | · | · | · | · | · | · |
Valorisation (TTM)
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $1.40B | $1.19B | $1.06B | $847M | $748M | $560M | $547M | · | $334M | $263M | |
| Net Income TTM | $178M | $14M | $91M | $-2M | $5M | $-16M | $48M | · | $5M | $15M | |
| Market Cap | $12.20B | $9.14B | $9.73B | $8.48B | $10.80B | $6.37B | $5.75B | · | $3.17B | $1.98B | |
| P/E | 68.8 | 659.7 | 108.4 | -4449.2 | 2052.3 | -397.7 | 122.6 | · | 723.8 | 145.0 | |
| P/S | 8.7 | 7.7 | 9.2 | 10.0 | 14.4 | 11.4 | 10.5 | · | 9.5 | 7.5 | |
| P/B | 8.5 | 7.9 | 8.3 | 8.5 | 11.3 | 9.9 | 11.8 | · | 7.9 | 7.4 | |
| P / Tangible Book | 9.7 | 9.3 | 10.3 | 11.3 | 15.5 | 10.3 | · | · | · | · | |
| P / Cash Flow | 51.1 | 54.3 | 100.0 | -152.3 | 1136.3 | -191.7 | 215.7 | · | 249.8 | -155.0 | |
| P / FCF | 69.7 | 62.1 | 118.5 | -113.1 | -924.6 | -109.9 | 1265.6 | · | 19935.7 | -75.1 | |
| Earnings Yield | 1.5% | 0.15% | 0.92% | -0.02% | 0.05% | -0.25% | 0.82% | · | 0.14% | 0.69% |
Compte de résultat
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $390M | $375M | $385M | $355M | $339M | $324M | $316M | $301M | $299M | $279M | $285M | $271M | $261M | $241M | $221M | $214M | |
| Cost of Revenue | $125M | $121M | $123M | $114M | $115M | $108M | $105M | $101M | $137M | $98M | $98M | $93M | $95M | $90M | $83M | $78M | |
| Gross Profit | $265M | $253M | $262M | $240M | $224M | $216M | $211M | $200M | $163M | $181M | $187M | $178M | $167M | $151M | $138M | $135M | |
| R&D Expense | · | · | · | · | · | · | · | · | · | · | · | · | $22M | $20M | · | $21M | |
| SG&A Expense | $199M | $193M | $181M | $169M | $160M | $153M | $148M | $140M | $142M | $144M | $130M | $126M | $127M | $123M | $116M | $109M | |
| Operating Expenses | $224M | $215M | $203M | $192M | $183M | $176M | $168M | $165M | $244M | $169M | $152M | $165M | $149M | $143M | $134M | $130M | |
| Operating Income | $41M | $38M | $59M | $49M | $41M | $40M | $43M | $35M | $-81M | $12M | $35M | $13M | $18M | $8M | $5M | $5M | |
| Interest Expense | · | · | · | · | · | · | · | · | $344.0K | $402.0K | · | · | $444.0K | $416.0K | · | · | |
| Interest Income | $6M | $5M | $5M | $4M | $4M | $3M | $3M | $3M | $4M | $3M | $3M | $2M | $1M | $970.0K | · | · | |
| Other Non-op | $-456.0K | $-1M | $171.0K | $-535.0K | $812.0K | $445.0K | $-1M | $1M | $-226.0K | $-366.0K | $559.0K | $-444.0K | $808.0K | $90.0K | $2M | $-2M | |
| Pretax Income | $46M | $42M | $64M | $52M | $45M | $44M | $44M | $40M | $-78M | $15M | $38M | $13M | $20M | $9M | $7M | $3M | |
| Income Tax | $11M | $9M | $16M | $6M | $0 | $5M | $11M | $10M | $-18M | $4M | $-16M | $4M | $576.0K | $90.0K | $3M | $5M | |
| Net Income | $35M | $33M | $47M | $46M | $45M | $39M | $34M | $30M | $-60M | $11M | $54M | $9M | $19M | $9M | $4M | $-2M | |
| EPS (Basic) | $0.88 | $0.83 | $1.21 | $1.17 | $1.17 | $1.02 | $0.87 | $0.76 | $-1.55 | $0.28 | $1.42 | $0.24 | $0.49 | $0.22 | $0.11 | $-0.06 | |
| EPS (Diluted) | $0.88 | $0.82 | $1.20 | $1.17 | $1.15 | $1.00 | $0.88 | $0.75 | $-1.55 | $0.28 | $1.39 | $0.23 | $0.48 | $0.22 | $0.11 | $-0.06 | |
| Shares (Basic) | 39,353,965 | 39,275,424 | · | 39,078,378 | 38,834,917 | 38,562,191 | · | 38,610,805 | 38,793,341 | 38,717,334 | 38,628,565 | 38,462,463 | 38,320,999 | 38,186,342 | 38,030,344 | 37,918,452 | |
| Shares (Diluted) | 39,572,059 | 39,543,780 | · | 39,302,239 | 39,245,953 | 39,163,428 | · | 39,178,227 | 38,793,341 | 39,387,359 | 39,291,044 | 39,219,966 | 39,201,155 | 39,075,388 | 38,896,940 | 37,918,452 | |
| EBITDA | $41M | $43M | · | $49M | $41M | $45M | · | $35M | $-81M | $20M | · | $13M | $18M | $15M | · | $5M |
Bilan
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $205M | $241M | $187M | $321M | $422M | $376M | $324M | $280M | $288M | $223M | · | $101M | $114M | $95M | · | $55M | |
| Receivables | $190M | $183M | $190M | $183M | $176M | $168M | $168M | $176M | $201M | $192M | · | $207M | $209M | $207M | · | $189M | |
| Inventory | $443M | $439M | $432M | $432M | $428M | $416M | $407M | $393M | $374M | $398M | · | $374M | $359M | $344M | · | $320M | |
| Prepaid Expense | $52M | $38M | $50M | $55M | $38M | $37M | $37M | $31M | $29M | $31M | · | $39M | $39M | $36M | · | $30M | |
| Current Assets | $1.34B | $1.28B | $1.22B | $1.14B | $1.07B | $1000M | $951M | $892M | $944M | $935M | · | $868M | $828M | $786M | · | $724M | |
| PP&E (Net) | $147M | $134M | $117M | $98M | $85M | $72M | $63M | $60M | $58M | $76M | · | $66M | $66M | $65M | · | $64M | |
| PP&E (Gross) | · | · | $194M | · | · | · | $137M | $132M | $143M | · | · | · | · | · | · | · | |
| Accum. Depreciation | · | · | $77M | · | · | · | $74M | $72M | $85M | · | · | · | · | · | · | · | |
| Goodwill | $167M | $167M | $167M | $167M | $167M | $166M | $166M | $166M | $166M | $166M | · | $166M | $166M | $166M | · | $165M | |
| Intangibles | $6M | $6M | $6M | $6M | $7M | $6M | $7M | $7M | $7M | $68M | · | $73M | $76M | $79M | · | $83M | |
| Other Non-current Assets | $41M | $41M | $41M | $40M | $40M | $44M | $41M | $39M | $39M | $34M | · | $15M | $10M | $11M | · | $13M | |
| Total Assets | $1.97B | $1.90B | $1.83B | $1.74B | $1.67B | $1.59B | $1.53B | $1.48B | $1.53B | $1.58B | · | $1.47B | $1.43B | $1.40B | · | $1.32B | |
| Accounts Payable | $45M | $44M | $35M | $30M | $28M | $31M | $31M | $33M | $33M | $32M | · | $28M | $26M | $28M | · | $25M | |
| Accrued Liabilities | $172M | $152M | $132M | $124M | $114M | $113M | $112M | $106M | $104M | $107M | · | $104M | $106M | $106M | · | $102M | |
| Current Liabilities | $234M | $212M | $183M | $170M | $158M | $159M | $158M | $153M | $151M | $153M | · | $145M | $144M | $146M | · | $138M | |
| Capital Leases | $176M | $179M | $183M | $180M | $183M | $185M | $187M | $190M | $192M | $195M | · | $192M | $195M | $197M | · | $181M | |
| Other Non-current Liabilities | $14M | $13M | $12M | $15M | $18M | $16M | $15M | $9M | $8M | $6M | · | $3M | $3M | $3M | · | $3M | |
| Total Liabilities | $444M | $425M | $399M | $386M | $381M | $380M | $382M | $375M | $373M | $376M | · | $364M | $366M | $371M | · | $348M | |
| Common Stock | $39.0K | $39.0K | $39.0K | $39.0K | $39.0K | $39.0K | $38.0K | $38.0K | $39.0K | $39.0K | · | $38.0K | $38.0K | $38.0K | · | $38.0K | |
| Paid-in Capital | $1.22B | $1.20B | $1.19B | $1.17B | $1.15B | $1.12B | $1.10B | $1.08B | $1.08B | $1.06B | · | $1.03B | $1.00B | $979M | · | $947M | |
| Retained Earnings | $305M | $270M | $238M | $190M | $144M | $99M | $60M | $26M | $86M | $146M | · | $81M | $71M | $52M | · | $40M | |
| AOCI | $1M | $2M | $4M | $3M | $3M | $-3M | $-6M | $-963.0K | $-5M | $-5M | · | $-7M | $-6M | $-7M | · | $-13M | |
| Stockholders' Equity | $1.53B | $1.47B | $1.43B | $1.36B | $1.29B | $1.21B | $1.15B | $1.10B | $1.16B | $1.20B | $1.18B | $1.10B | $1.07B | $1.02B | $999M | $974M | |
| Liabilities + Equity | $1.97B | $1.90B | $1.83B | $1.74B | $1.67B | $1.59B | $1.53B | $1.48B | $1.53B | $1.58B | · | $1.47B | $1.43B | $1.40B | · | $1.32B | |
| Shares Outstanding | · | · | 39,229,670 | · | · | · | 38,490,836 | · | · | · | · | · | · | · | · | · |
Flux de trésorerie
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $6M | $5M | $4M | $2M | $6M | $5M | $4M | $4M | $8M | $8M | $7M | $7M | $7M | $7M | $6M | $6M | |
| Stock-based Comp | $14M | $15M | $15M | $16M | $14M | $14M | $12M | $11M | $10M | $14M | $11M | $14M | $13M | $13M | $10M | $10M | |
| Amort. of Intangibles | $181.0K | $182.0K | $182.0K | $182.0K | $178.0K | $170.0K | $170.0K | $176.0K | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | |
| Restructuring | · | · | · | · | · | · | · | $5M | · | · | · | · | · | · | · | · | |
| Other Non-cash | · | $35M | · | · | · | $-9M | · | · | · | $6M | · | · | · | $-15M | · | · | |
| Operating Cash Flow | $46M | $87M | $86M | $58M | $45M | $49M | $51M | $56M | $23M | $38M | $36M | $31M | $17M | $13M | $1M | $-13M | |
| CapEx | $14M | $14M | $18M | $16M | $16M | $13M | $5M | $5M | $5M | $6M | $4M | $3M | $4M | $4M | $4M | $6M | |
| Investing Cash Flow | $-91M | $-31M | $-226M | $-163M | $-16M | $-502.0K | $-11M | $36M | $34M | $18M | $24M | $-44M | $-7M | $11M | $9M | $10M | |
| Stock Repurchased | · | · | $0 | · | · | · | $-1.0K | · | · | · | $0 | · | · | · | · | · | |
| Financing Cash Flow | $9M | $-2M | $5M | $4M | $15M | $3M | $6M | $-101M | $8M | $-794.0K | $6M | $212.0K | $9M | $1M | $6M | $-603.0K | |
| Net Change in Cash | $-36M | $54M | $-134M | $-101M | $46M | $52M | $44M | $-8M | $65M | $56M | $67M | $-13M | $19M | $25M | $15M | $-3M | |
| Free Cash Flow | · | $73M | · | · | · | $36M | · | · | · | $32M | · | · | · | $9M | · | · | |
| Levered FCF | · | · | · | · | · | · | · | · | · | $32M | · | · | · | · | · | · |
Rentabilité
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 67.9% | 67.6% | · | 67.8% | 66.0% | 66.6% | · | 66.5% | 54.4% | 65.0% | · | 65.6% | 63.8% | 62.6% | · | 63.3% | |
| Operating Margin | 10.5% | 10.2% | · | 13.8% | 12.0% | 12.4% | · | 11.8% | -27.0% | 4.3% | · | 4.7% | 6.8% | 3.3% | · | 2.5% | |
| Net Margin | 8.9% | 8.7% | · | 12.9% | 13.3% | 12.1% | · | 9.8% | -20.1% | 4.0% | · | 3.4% | 7.2% | 3.5% | · | -1.1% | |
| Pretax Margin | 11.8% | 11.1% | · | 14.8% | 13.4% | 13.5% | · | 13.2% | -26.0% | 5.2% | · | 4.9% | 7.5% | 3.6% | · | 1.4% | |
| EBITDA Margin | 10.5% | 11.4% | · | 13.8% | 12.0% | 14.0% | · | 11.8% | -27.0% | 7.0% | · | 4.7% | 6.8% | 6.0% | · | 2.5% | |
| ROA | 1.9% | 1.9% | · | 2.8% | 2.8% | 2.5% | · | 2.0% | -4.1% | 0.74% | · | 0.66% | 1.4% | 0.63% | · | -0.20% | |
| ROE | 2.5% | 2.4% | · | 3.7% | 3.7% | 3.2% | · | 2.7% | -5.4% | 0.99% | · | 0.89% | 1.9% | 0.86% | · | -0.27% | |
| ROIC | 2.0% | 2.0% | · | 3.1% | 3.2% | 3.0% | · | 2.4% | -5.4% | 0.76% | · | 0.79% | 1.6% | 0.77% | · | -0.42% |
Liquidité et Solvabilité
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 5.7 | 6.0 | · | 6.7 | 6.8 | 6.3 | · | 5.8 | 6.3 | 6.1 | · | 6.0 | 5.7 | 5.4 | · | 5.2 | |
| Quick Ratio | 1.7 | 2.0 | · | 3.0 | 3.8 | 3.4 | · | 3.0 | 3.2 | 2.7 | · | 2.1 | 2.2 | 2.1 | · | 1.8 | |
| Interest Coverage | · | · | · | · | · | · | · | · | -235.4 | 30.1 | · | · | · | · | · | · |
Efficacité
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.2 | · | 0.2 | |
| Inventory Turnover | 0.3 | 0.3 | · | 0.3 | 0.3 | 0.3 | · | 0.3 | 0.4 | 0.3 | · | 0.3 | 0.3 | 0.3 | · | 0.3 | |
| Receivables Turnover | 2.1 | 2.1 | · | 2.0 | 1.8 | 1.8 | · | 1.6 | 1.5 | 1.4 | · | 1.4 | 1.3 | 1.4 | · | 1.4 |
Par action
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue / Share | $9.86 | $9.48 | · | $9.02 | $8.65 | $8.28 | · | $7.68 | $7.72 | $7.07 | · | $6.91 | $6.67 | $6.18 | · | $5.64 | |
| Cash Flow / Share | · | $2.20 | · | · | · | $1.25 | · | · | · | $0.97 | · | · | · | $0.34 | · | · | |
| EPS (TTM) | $4.07 | $4.34 | · | $4.20 | $3.78 | $1.08 | · | $0.87 | $0.35 | $2.38 | · | $1.04 | $0.75 | $0.17 | · | $-0.83 |
Valorisation (TTM)
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $1.50B | $1.45B | · | $1.33B | $1.28B | $1.24B | · | $1.16B | $1.13B | $1.10B | · | $995M | $938M | $885M | · | $830M | |
| Net Income TTM | $161M | $171M | · | $164M | $148M | $42M | · | $35M | $14M | $93M | · | $41M | $29M | $6M | · | $-31M | |
| P/E | 77.6 | 75.7 | · | 60.3 | 67.9 | 247.6 | · | 223.3 | 514.2 | 93.8 | · | 232.6 | 458.7 | 1639.4 | · | -228.4 | |
| Earnings Yield | 1.3% | 1.3% | · | 1.7% | 1.5% | 0.40% | · | 0.45% | 0.19% | 1.1% | · | 0.43% | 0.22% | 0.06% | · | -0.44% |
Période la plus récente à gauche · valeurs nulles affichées comme ·
États financiers Compte de résultat, bilan, flux de trésorerie — annuel, sur les 5 dernières années
| Métrique | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Revenu | $1.40B | $1.19B | $1.06B | $847M | $748M |
| Marge Brute % | 67.1% | 63.2% | 64.5% | 63.2% | 63.6% |
| Marge d'exploitation % | 13.5% | 0.78% | 7.0% | 0.72% | -1.0% |
| Résultat net | $178M | $14M | $91M | $-2M | $5M |
| BPA dilué | $4.52 | $0.36 | $2.32 | $-0.05 | $0.14 |
| Métrique | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Ratio de liquidité | 6.6 | 6.0 | 6.1 | 5.2 | 5.5 |
| Ratio de liquidité réduite | 2.1 | 3.1 | 2.4 | 1.9 | 1.6 |
| Métrique | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Flux de trésorerie libre | $175M | $147M | $82M | $-75M | $-12M |
Détenteurs institutionnels (13F) 490 déclarants · $12.1B total · Au 30 septembre 2026
Institutions qui déclarent détenir cette action dans leur Formulaire SEC 13F trimestriel. Uniquement les positions longues ; un même déclarant peut apparaître deux fois pour des jambes d'options distinctes. Les jambes put/call compensatoires importantes reflètent généralement la tenue de marché ou un inventaire couvert, pas une conviction directionnelle.
Détenteurs
490
Valeur détenue
$12.1B
Nouvelles positions
46
Positions clôturées
67
Activité institutionnelle — Q2 2026 vs trimestre précédent
| Nouvelles positions | Positions clôturées | Augmenté | Diminué | Variation nette des actions |
|---|---|---|---|---|
| 46 (-96 vs T. préc.) | 67 (-9 vs T. préc.) | 148 (-1 vs T. préc.) | 186 (+50 vs T. préc.) | +877K |
Comparé à Q1 2026. Les dépôts de formulaire 13F de la SEC sont dus dans les 45 jours suivant la fin du trimestre, plus une courte période tampon pour les déposants tardifs — les trimestres encore dans cette fenêtre sont ignorés au profit de la paire la plus récente entièrement déclarée.
| Institution | Valeur | Actions | % de 13F suivies | Type |
|---|---|---|---|---|
| BlackRock, Inc. | $1 356 952 992 | 4 297 555 | 11,19% | Actions |
| VANGUARD GROUP INC | $1 172 307 607 | 3 770 569 | 9,67% | Actions |
| HBK INVESTMENTS L P | $580 508 901 | 1 838 508 | 4,79% | Actions |
| VANGUARD CAPITAL MANAGEMENT LLC | $539 893 663 | 1 709 877 | 4,45% | Actions |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $526 442 397 | 1 667 276 | 4,34% | Actions |
| STATE STREET CORP | $392 556 505 | 1 243 258 | 3,24% | Actions |
| ExodusPoint Capital Management, LP | $344 303 272 | 1 090 430 | 2,84% | Actions |
| Balyasny Asset Management L.P. | $344 218 967 | 1 090 163 | 2,84% | Actions |
| JPMORGAN CHASE & CO | $338 557 982 | 1 071 454 | 2,79% | Actions |
| GOLDMAN SACHS GROUP INC | $267 473 088 | 847 104 | 2,21% | Actions |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $263 620 622 | 834 903 | 2,17% | Actions |
| GEODE CAPITAL MANAGEMENT, LLC | $251 546 090 | 796 471 | 2,07% | Actions |
| NORGES BANK | $237 520 412 | 752 242 | 1,96% | Actions |
| UBS Group AG | $222 231 798 | 703 822 | 1,83% | Actions |
| MILLENNIUM MANAGEMENT LLC | $221 217 923 | 700 611 | 1,82% | Actions |
| MORGAN STANLEY | $186 869 151 | 591 824 | 1,54% | Actions |
| AQR Arbitrage LLC | $178 042 900 | 563 873 | 1,47% | Actions |
| WHITEBOX ADVISORS LLC | $160 047 676 | 506 881 | 1,32% | Actions |
| Capital World Investors | $151 465 591 | 479 701 | 1,25% | Actions |
| CITADEL ADVISORS LLC | $141 696 917 | 448 763 | 1,17% | Actions |
| NEUBERGER BERMAN GROUP LLC | $138 473 110 | 438 553 | 1,14% | Actions |
| CITIGROUP INC | $136 759 219 | 433 125 | 1,13% | Actions |
| TWO SIGMA INVESTMENTS, LP | $135 181 416 | 428 128 | 1,11% | Actions |
| TUDOR INVESTMENT CORP ET AL | $126 504 922 | 400 649 | 1,04% | Actions |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $108 527 380 | 343 713 | 0,89% | Actions |
| NORTHERN TRUST CORP | $105 164 958 | 333 064 | 0,87% | Actions |
| DIMENSIONAL FUND ADVISORS LP | $102 972 179 | 326 120 | 0,85% | Actions |
| ALLIANCEBERNSTEIN L.P. | $99 031 466 | 301 585 | 0,82% | Actions |
| BANK OF AMERICA CORP /DE/ | $83 994 867 | 266 017 | 0,69% | Actions |
| Invesco Ltd. | $83 351 684 | 263 980 | 0,69% | Actions |
| Magnetar Financial LLC | $80 781 796 | 255 841 | 0,67% | Actions |
| VANGUARD FIDUCIARY TRUST CO | $79 488 800 | 251 746 | 0,66% | Actions |
| Bank of New York Mellon Corp | $74 304 811 | 235 328 | 0,61% | Actions |
| Champlain Investment Partners, LLC | $69 159 354 | 219 032 | 0,57% | Actions |
| TIG Advisors, LLC | $67 912 141 | 215 082 | 0,56% | Actions |
| LMR Partners LLP | $67 536 715 | 213 893 | 0,56% | Actions |
| FMR LLC | $66 623 786 | 211 002 | 0,55% | Actions |
| Hudson Bay Capital Management LP | $64 140 823 | 203 138 | 0,53% | Actions |
| MILLENNIUM MANAGEMENT LLC | $63 150 000 | 200 000 | 0,52% | Option de vente |
| D. E. Shaw & Co., Inc. | $62 306 632 | 197 329 | 0,51% | Actions |
| ALPINE ASSOCIATES MANAGEMENT INC. | $59 672 330 | 188 986 | 0,49% | Actions |
| Melqart Asset Management (UK) Ltd | $58 645 511 | 185 734 | 0,48% | Actions |
| CAXTON ASSOCIATES LLP | $56 640 498 | 179 384 | 0,47% | Actions |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | $55 799 340 | 176 720 | 0,46% | Actions |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $55 540 425 | 175 900 | 0,46% | Option de vente |
| JANUS HENDERSON GROUP PLC | $54 849 328 | 167 054 | 0,45% | Actions |
| Birnam Oak Advisors, LP | $54 080 713 | 171 277 | 0,45% | Actions |
| Westchester Capital Management, LLC | $49 721 784 | 157 472 | 0,41% | Actions |
| WATER ISLAND CAPITAL LLC | $47 506 483 | 150 456 | 0,39% | Actions |
| Woodline Partners LP | $46 050 243 | 145 844 | 0,38% | Actions |
Initiés de la société 19 initiés · 5 dirigeants · 7 administrateurs
| Dirigeant | Rôle | Dernière activité | Actions détenues | Achats 12m | Ventes 12m | Net 12m |
|---|---|---|---|---|---|---|
| Adam Elsesser | CEO | 19 mai 2026 G | 683 042 | 0 | 0 | $0 |
| Maggie Yuen | Chief Financial Officer | 15 mars 2026 F | 18 167 | 0 | 1 | $-832 474 |
| Shruthi Narayan | President | 15 septembre 2026 F | 32 650 | 0 | 0 | $0 |
| Lambert Shiu | Chief Accounting Officer | 15 mars 2026 F | 39 323 | 0 | 0 | $0 |
| Johanna Roberts | EVP, Gen. Counsel & Secretary | 15 mars 2026 F | 67 298 | 0 | 16 | $-967 303 |
| Surbhi Sarna | Administrateur | 13 février 2026 A | 4 293 | 0 | 0 | $0 |
| Janet Leeds | Administrateur | 13 février 2026 A | 6 639 | 0 | 0 | $0 |
| Bridget O'Rourke | Administrateur | 13 février 2026 A | 5 962 | 0 | 0 | $0 |
| Arani Bose | Administrateur | 13 février 2026 A | 1 147 | 0 | 10 | $-9 062 931 |
| Thomas Wilder | Administrateur | 13 février 2026 A | 589 | 0 | 1 | $-57 794 |
| Walter Charles Wang | Administrateur | 4 mars 2016 A | 521 071 | 0 | 0 | $0 |
| Harpreet Grewal | · | 2 avril 2026 S | 8 719 | 0 | 4 | $-162 601 |
| Don W. Kassing | · | 14 février 2025 A | 1 409 | 0 | 0 | $0 |
| James Robert Pray | · | 1 octobre 2021 S | 408 431 | 0 | 0 | $0 |
| Lynn Rothman | · | 1 octobre 2021 M | 32 637 | 0 | 0 | $0 |
| Sridhar Kosaraju | · | 15 avril 2020 S | 155 351 | 0 | 0 | $0 |
| Daniel Donen Davis | · | 27 décembre 2018 M | 64 277 | 0 | 0 | $0 |
| Robert D. Evans | · | 30 août 2018 M | 15 667 | 0 | 0 | $0 |
| Kevin James Sullivan | · | 31 août 2016 S | 29 449 | 0 | 0 | $0 |
Initiés issus des déclarations SEC Form 3/4/5 ; net = uniquement P/S de marché
Détention d'ETF Détenu par 67 ETFs
Le poids reflète uniquement les participations directes en actions (N-PORT) ; les fonds à effet de levier ou basés sur des dérivés peuvent détenir une exposition supplémentaire aux swaps non indiquée.
| Fonds | Poids | Unités | Au | Source |
|---|---|---|---|---|
| RSBA · Tidal Trust II | 4,65% | 7 617 NS | 31 juillet 2026 | N-PORT |
| NEWZ · EA Series Trust | 3,43% | 2 085 NS | 31 juillet 2026 | N-PORT |
| MNA · New York Life Investments ETF Trust | 2,11% | 16 553 NS | 31 juillet 2026 | N-PORT |
| IHI · iShares Trust | 1,88% | 188 033 SH | 11 septembre 2026 | Quotidien |
| HTEC · EXCHANGE TRADED CONCEPTS TRUST | 1,65% | 3 558 NS | 31 juillet 2026 | N-PORT |
| RFG · Invesco Exchange-Traded Fund Trust | 0,95% | 9 963 SH | 2 octobre 2026 | Quotidien |
| MEDI · Harbor ETF Trust | 0,77% | 987 NS | 31 juillet 2026 | N-PORT |
| IVOG · VANGUARD ADMIRAL FUNDS | 0,65% | 38 809 SH | 19 août 2026 | Quotidien |
| IQSM · New York Life Investments ETF Trust | 0,46% | 4 773 NS | 31 juillet 2026 | N-PORT |
| PAMC · Pacer Funds Trust | 0,43% | 712 NS | 31 juillet 2026 | N-PORT |
| ISCG · iShares Trust | 0,40% | 12 024 SH | 11 septembre 2026 | Quotidien |
| NUSC · Nushares ETF Trust | 0,39% | 15 774 NS | 31 juillet 2026 | N-PORT |
| PTMC · Pacer Funds Trust | 0,36% | 4 350 NS | 31 juillet 2026 | N-PORT |
| IWP · iShares Trust | 0,36% | 214 670 SH | 11 septembre 2026 | Quotidien |
| IVOO · VANGUARD ADMIRAL FUNDS | 0,34% | 63 544 SH | 19 août 2026 | Quotidien |
| VBK · VANGUARD INDEX FUNDS | 0,32% | 495 123 SH | 19 août 2026 | Quotidien |
| BKMC · BNY Mellon ETF Trust | 0,31% | 6 335 NS | 31 juillet 2026 | N-PORT |
| JPME · J.P. Morgan Exchange-Traded Fund Tr… | 0,30% | 4 348 NS | 31 juillet 2026 | N-PORT |
| SMDX · Tidal Trust III | 0,29% | 1 182 NS | 31 juillet 2026 | N-PORT |
| MIDU · Direxion Shares ETF Trust | 0,27% | 578 NS | 31 juillet 2026 | N-PORT |
| BBMC · J.P. Morgan Exchange-Traded Fund Tr… | 0,26% | 16 632 NS | 31 juillet 2026 | N-PORT |
| FSMD · FIDELITY COVINGTON TRUST | 0,23% | 18 226 NS | 31 juillet 2026 | N-PORT |
| JQUA · J.P. Morgan Exchange-Traded Fund Tr… | 0,20% | 50 475 NS | 31 juillet 2026 | N-PORT |
| IYH · iShares Trust | 0,19% | 22 263 SH | 11 septembre 2026 | Quotidien |
| FHLC · FIDELITY COVINGTON TRUST | 0,17% | 17 746 NS | 31 juillet 2026 | N-PORT |
| JMOM · J.P. Morgan Exchange-Traded Fund Tr… | 0,17% | 13 412 NS | 31 juillet 2026 | N-PORT |
| ESML · iShares Trust | 0,17% | 15 152 SH | 11 septembre 2026 | Quotidien |
| VHT · VANGUARD WORLD FUND | 0,17% | 112 334 SH | 19 août 2026 | Quotidien |
| SMMD · iShares Trust | 0,17% | 20 300 SH | 11 septembre 2026 | Quotidien |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,15% | 12 370 SH | 2 octobre 2026 | Quotidien |
| VXF · VANGUARD INDEX FUNDS | 0,14% | 451 358 SH | 19 août 2026 | Quotidien |
| VB · VANGUARD INDEX FUNDS | 0,14% | 856 800 SH | 19 août 2026 | Quotidien |
| DFAS · Dimensional ETF Trust | 0,12% | 59 193 NS | 31 juillet 2026 | N-PORT |
| WSML · iShares Trust | 0,11% | 2 287 SH | 11 septembre 2026 | Quotidien |
| EQAL · Invesco Exchange-Traded Fund Trust … | 0,09% | 2 375 SH | 2 octobre 2026 | Quotidien |
| IWR · iShares Trust | 0,09% | 156 309 SH | 11 septembre 2026 | Quotidien |
| RILA · Spinnaker ETF Series | 0,07% | 88 NS | 31 juillet 2026 | N-PORT |
| XT · iShares Trust | 0,07% | 8 117 SH | 11 septembre 2026 | Quotidien |
| RWK · Invesco Exchange-Traded Fund Trust … | 0,06% | 2 477 SH | 2 octobre 2026 | Quotidien |
| VONG · VANGUARD SCOTTSDALE FUNDS | 0,04% | 60 327 SH | 19 août 2026 | Quotidien |
| IWF · iShares Trust | 0,04% | 143 096 SH | 11 septembre 2026 | Quotidien |
| IUSG · iShares Trust | 0,03% | 35 012 SH | 11 septembre 2026 | Quotidien |
| OMFL · Invesco Exchange-Traded Self-Indexe… | 0,03% | 3 819 SH | 2 octobre 2026 | Quotidien |
| TILT · FlexShares Trust | 0,02% | 1 422 NS | 31 juillet 2026 | N-PORT |
| VTI · VANGUARD INDEX FUNDS | 0,02% | 1 186 275 SH | 19 août 2026 | Quotidien |
| VONE · VANGUARD SCOTTSDALE FUNDS | 0,02% | 6 349 SH | 19 août 2026 | Quotidien |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,02% | 3 208 SH | 19 août 2026 | Quotidien |
| ESGV · VANGUARD WORLD FUND | 0,02% | 8 611 SH | 19 août 2026 | Quotidien |
| DFAC · Dimensional ETF Trust | 0,02% | 27 709 NS | 31 juillet 2026 | N-PORT |
| IYY · iShares Trust | 0,02% | 1 685 SH | 10 septembre 2026 | Quotidien |
| IWB · iShares Trust | 0,02% | 26 117 SH | 11 septembre 2026 | Quotidien |
| ITOT · iShares Trust | 0,02% | 50 889 SH | 11 septembre 2026 | Quotidien |
| IWV · iShares Trust | 0,02% | 10 594 SH | 10 septembre 2026 | Quotidien |
| DFAU · Dimensional ETF Trust | 0,02% | 6 022 NS | 31 juillet 2026 | N-PORT |
| DFUS · Dimensional ETF Trust | 0,02% | 9 928 NS | 31 juillet 2026 | N-PORT |
| DCOR · Dimensional ETF Trust | 0,01% | 1 400 NS | 31 juillet 2026 | N-PORT |
| DFSU · Dimensional ETF Trust | 0,01% | 810 NS | 31 juillet 2026 | N-PORT |
| VT · VANGUARD INTERNATIONAL EQUITY INDEX… | 0,01% | 30 658 SH | 19 août 2026 | Quotidien |
| EPU · iShares Trust | 0,00% | 19 935 SH | 11 septembre 2026 | Quotidien |
| DYNF · BlackRock ETF Trust | 0,00% | 42 SH | 24 août 2026 | Quotidien |
| EEMS · iShares, Inc. | 0,00% | 100 SH | 26 août 2026 | Quotidien |
| IJH · iShares Trust | · | 1 380 497 SH | 11 septembre 2026 | Quotidien |
| IJK · iShares Trust | · | 228 092 SH | 11 septembre 2026 | Quotidien |
| XJH · iShares Trust | · | 5 373 SH | 8 septembre 2026 | Quotidien |
| ISCB · iShares Trust | · | 1 708 SH | 11 septembre 2026 | Quotidien |
| SMLF · iShares Trust | · | 10 495 SH | 11 septembre 2026 | Quotidien |
| SMMV · iShares Trust | · | 5 954 SH | 1 septembre 2026 | Quotidien |
PEN Consensus des analystes Opinions des analystes haussières et baissières, objectif de cours à 12 mois, potentiel de hausse
notation · 20 analystes
CONSERVER
Objectif médian
$374.00
+17,8%
1 5,0%
Achat fort
5 25,0%
Achat
14 70,0%
Conserver
0 0,0%
Vente
0 0,0%
Vente forte
Objectif de cours à 12 mois
12 analystes · 2026-10-02Objectif moyen $361.83 +13,9%
← En dessous de tous les objectifs
Prix actuel $317.55
Bas$323.00
Moyenne$361.83
Haut$374.00
Comparaison des pairs (sous-secteur GICS) Indicateurs clés par rapport aux pairs du secteur
Base F.A., prix à la clôture de la dernière fin d'exercice de chaque société.
| Ticker | Capitalisation Boursière | P/E | Revenus Année/Année | Marge Nette | ROE | Marge Brute |
|---|---|---|---|---|---|---|
| PEN | $12.20B | 68.8 | 17.5% | 12.7% | 13.1% | 67.1% |
| DXCM | $25.54B | 31.8 | 15.6% | 17.9% | 31.4% | 60.1% |
| RMD | $28.11B | 18.7 | 9.8% | 26.9% | 23.6% | 61.1% |
| GEHC | · | 18.0 | 4.8% | 10.1% | 22.1% | 40.0% |
| ZBH | $28.66B | 25.3 | 7.2% | 8.6% | 5.6% | · |
| BAX | $13.05B | -10.2 | 5.7% | -8.5% | -14.6% | 30.0% |
| GMED | · | 22.3 | 16.7% | 18.3% | 12.1% | · |
| GKOS | $6.49B | -34.4 | 32.3% | -37.0% | -26.4% | 55.7% |
| PODD | $20.01B | 81.7 | 30.7% | 9.1% | 16.6% | 71.6% |
| TFX | · | -6.0 | 17.2% | -45.5% | -24.6% | 56.2% |
| ABT | $250.18B | 33.7 | 5.7% | 14.7% | 13.1% | · |
Mes métriques Votre watchlist personnelle — lignes sélectionnées de Fondamentaux Complets
Choisissez les indicateurs qui vous importent — cliquez sur le + à côté de n'importe quelle ligne dans les Fondamentaux complets ci-dessus.
Votre sélection est enregistrée et vous suit sur tous les tickers.
Source : Dépôt SEC 10-Q le Jul 30, 2026